Lord, Abbett & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $30.7M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $125M | Buy |
|
|||||
|
2022
Q3 | $104M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $7.12M | Sell |
|
|||||
|
2021
Q3 | $52.9M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $35.4M | Buy |
|
|||||
|
2017
Q4 | $32.6M | Buy |
|
|||||
|
2017
Q3 | $13.6M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $16M | Sell |
|
|||||
|
2015
Q1 | $35.8M | Buy |
|
|||||
|
2014
Q4 | $27.6M | Sell |
|
|||||
|
2014
Q3 | $54M | Sell |
|
|||||
|
2014
Q2 | $47M | Buy |
|
|||||
|
2014
Q1 | $9.53M | Sell |
|
|||||
|
2013
Q4 | $20.6M | Sell |
|
|||||
|
2013
Q3 | $37.4M | Sell |
|
|||||
|
2013
Q2 | $31.8M | Buy |
|